Publications

Publications

Article
Mimura W, Ishiguro C, Maeda M, Murata F, Fukuda H.
Association between mRNA COVID-19 vaccine boosters and mortality in Japan: The VENUS Study.
Human Vaccines & Immunotherapeutics 2024; 20(1): 2350091.
Mimura W, Ishiguro C, Terada-Hirashima J, Matsunaga N, Sato S, Kawazoe Y, Maeda M, Murata F, Fukuda H.
Effectiveness of BNT162b2 against infection, symptomatic infection, and hospitalization among older adults aged ≥65 years during the Delta variant predominance in Japan: The VENUS Study.
Journal of Epidemiology 2024; 34(6): 278-285.
Sato S, Kawazoe Y, Katsuta T, Fukuda H.
Comparison design and evaluation power in cohort and self- controlled case series designs for post-authorization vaccine safety studies.
PeerJ 2024; 12: e16780.
Murata F, Maeda M, Murayama K, Nakao T, Fukuda H.
Associations between COVID-19 vaccination and incident psychiatric disorders after breakthrough SARS-CoV-2 infection: The VENUS Study.
Brain Behavior and Immunity 2024; 117: 521-528.
Murata F, Maeda M, Ono R, Fukuda H.
Association Between Regular Physical Activity and Pneumonia-Related Hospitalization According to Pneumococcal Vaccination Status: The VENUS Study.
Vaccine 2024; 42(6): 1268-1274.
Tamada Y, Takeuchi K, Kusama T, Maeda M, Murata F, Osaka K, Fukuda H.
Bivalent mRNA Vaccine Effectiveness and Hybrid Immunity against COVID-19 among Older Adults in Japan: A Test-negative Study from the VENUS Study.
BMC Infectious Diseases 2024; 24(1): 135.
Yamada N, Nakatsuka K, Tezuka M, Murata F, Maeda M, Akisue T, Fukuda H, Ono R.
Pneumococcal vaccination coverage and vaccination-related factors among older adults in Japan: LIFE Study.
Vaccine 2024; 42(2): 239-245.
Sato S, Katsuta T, Kawazoe Y, Takahashi M, Murata F, Maeda M, Fukuda H, Kamidani S.
Immune thrombocytopenic purpura and Guillain-Barré syndrome after 23-valent pneumococcal polysaccharide vaccination in Japan: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.
Vaccine 2024; 42(1): 4-7.
Mimura W, Ishiguro C, Terada-Hirashima J, Matsunaga N, Maeda M, Murata F, Fukuda H.
Bivalent vaccine effectiveness among older adults aged ≥65 years during the BA.5 predominant period in Japan: the VENUS Study.
Open Forum Infectious Diseases 2023; 10(10): ofad475.
Tsuzuki S, Murata F, Maeda M, Asai Y, Koizumi R, Ohmagari N, Fukuda H.
The association between seasonal influenza vaccination and antimicrobial use in Japan from the 2015-2016 to 2020-2021 seasons: from the VENUS study.
Journal of Antimicrobial Chemotherapy 2023; 78(12): 2976-2982.
1 2 3